HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,449-2,460 of 4,505
Drug study icon
CompletedNCT00334126

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in people with Schizophrenia

Official study title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Paliperidone ER Compared to Quetiapine in Subjects With an Acute Exacerbation of Schizophrenia

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18–65
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00299702

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in people with Schizophrenia

What is this study about?

Researchers compared Risperidal Consta and Abilify to find out how the approaches affected how long people remain free of a new mood episode in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Behavioral study icon
CompletedNCT03338179

Evaluation of Metamemory in people with Schizophrenia

Official study title

Evaluation of Metamemory in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Clermont-Ferrand
SchizophreniaBehavioural studyAges 18+
Countries
France
Sponsor
University Hospital, Clermont-Ferrand
Drug study icon
CompletedNCT01263080

Evaluation of Mirtazapine and Folic Acid for Schizophrenia:

Official study title

Multicentre Randomised Double-blind, Placebo-controlled 2x2 Factorial Trial Investigating the Effects of Adding Mirtazapine and Folic Acid to Existing Therapy for Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Beijing
SchizophreniaMedication studyAges 18–70
Countries
China
Sponsor
Capital Medical University
Drug study icon
CompletedNCT00097942

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

Official study title

A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients With Persistent Residual Symptoms

This study has finished and is no longer accepting participants.

Multiple locations, including National City
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Forest Laboratories

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.